NCT02534272

Brief Summary

D.fragilis is an intestinal protozoon that feeds by phagocytosis of intestinal bacteria. The study aim to determine if the carriage of the intestinal parasite D.fragilis is associated to changes of gut microbiota in subjects presenting with or without intestinal symptoms.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Geographic Reach
1 country

4 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 27, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

February 16, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 29, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2019

Completed
Last Updated

March 12, 2025

Status Verified

March 1, 2025

Enrollment Period

3.1 years

First QC Date

August 24, 2015

Last Update Submit

March 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • 16SrRNA copy numbers

    Within the 2 days following inclusion

Study Arms (2)

Symptomatic subjects

Subjects with intestinal symptoms

Other: Stool sampling and sequencing of gut microbiota.

Asymptomatic subjects

Subjects without intestinal symptoms

Other: Stool sampling and sequencing of gut microbiota.

Interventions

Asymptomatic subjectsSymptomatic subjects

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Symptomatic subjects will be recruited during their visit to hospital for intestinal symptoms. Asymptomatic subjects will be recruited in the general population.

You may qualify if:

  • male/female aged at least of 18 years
  • subject with abdominal pain, diarrhea, bloating
  • no other known intestinal disease
  • male/female aged at least of 18 years
  • no known intestinal disease

You may not qualify if:

  • chronic intestinal diseases such as IBD, IBS …
  • intake of antibiotic or probiotic within the 2 last months
  • subject unable to understand information for a free consent to the study
  • subject in safeguarding justice or guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Laboratoire de Parasitologie et de Mycologie Médicale du Plateau Technique de Microbiologie des Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

Médecine interne, maladies tropicales et infectieuses Hôpital Civil

Strasbourg, 67091, France

Location

Service de Médecine Interne - Diabète et Maladies métaboliques Hôpital Civil

Strasbourg, 67091, France

Location

Service d'hépato gastro-entérologie et assistance nutritive Hôpital Hautepierre

Strasbourg, 67098, France

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Stool

MeSH Terms

Conditions

Diarrhea

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • CANDOLFI Ermanno, MD

    Hôpitaux Universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2015

First Posted

August 27, 2015

Study Start

February 16, 2016

Primary Completion

March 29, 2019

Study Completion

March 29, 2019

Last Updated

March 12, 2025

Record last verified: 2025-03

Locations